Market Overview:
The global diarrhea drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diarrhea, rising awareness about available treatments, and growing demand for over-the-counter (OTC) drugs. By type, the prescription drugs segment is expected to account for a larger share of the global diarrhea drug market in 2018. However, the OTC drugs segment is projected to grow at a higher CAGR during the forecast period. By application, adults are expected to account for a larger share of the global diarrhea drug market in 2018; however, children are projected to grow at a higher CAGR during the forecast period.
Product Definition:
A drug used to treat diarrhea. It is important because it helps to stop the diarrhea and allows the person to feel better.
Prescription Drugs:
Prescription drugs are medicines that are given to patients by doctors or other healthcare professionals after a diagnosis has been made. Prescription drug market is expected to grow at a lucrative rate over the forecast period owing to factors such as increasing prevalence of chronic diseases, rising geriatric population base and growing awareness about the benefits of prescription drugs in diarrhea treatment.
OTC Drugs:
OTC drugs are those medicines which are sold over the counter. Owing to this characteristic, these drugs do not require a prescription from healthcare professionals and hence they can be used for treating diarrhea as well as other gastrointestinal disorders. These medications can be used for children above three years of age and adults also.
Application Insights:
The adult segment held the largest share of over 70.0% in 2017. The application of diarrhea drugs is highest among adults as they are more susceptible to bacterial diarrhea than children owing to their larger body size and development stage. Moreover, a high number of chronic diseases such as cancer, diabetes and cardiovascular diseases are prevalent among adults which increases the risk of developing diarrhea. Thus, increasing incidences of infectious diseases coupled with growing geriatric population across the world is expected to drive demand for these drugs in near future.
Diarrhea caused due to viruses does not respond well to OTC treatments as they do not contain enough medicine for treating such infections which makes them inappropriate for such cases. However, there are prescription anti-diarrheal medicines that can be used against viral infections; these will be covered under another category called pediatric applications during this study period (2018-2030).
Regional Analysis:
North America dominated the global diarrhea drug market in 2017. The region is expected to maintain its position during the forecast period. High prevalence of infectious diseases, such as rotavirus and shigella, has been identified as a major factor responsible for the dominance of North America. According to data published by CDC’s National Center for Health Statistics (NCHS), in 2016 around 870,000 cases of hospitalizations were reported due to diarrhea among U.S children under 5 years of age.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing rising awareness about hygiene and safety along with rapid economic development especially in India & China and Indonesia & Malaysia etc.
Growth Factors:
- Increasing incidence of diarrhea due to changing lifestyle and food habits
- Rising awareness about the benefits of using diarrhea drugs
- Growing demand for over-the-counter (OTC) drugs for the treatment of diarrhea
- Proliferation of retail pharmacies and drug stores across emerging markets
- Launch of novel, innovative and affordable products by key players in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
Diarrhea Drug Market Research Report
By Type
Prescription Drugs, OTC Drugs
By Application
Adult, Children
By Companies
HPGC, Simcere, Hailisheng, Sichuan Weiao, Shanxi Kangxin, Ipsen, Evaluate, Potion-Pharm, Gamay, HPGC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Diarrhea Drug Market Report Segments:
The global Diarrhea Drug market is segmented on the basis of:
Types
Prescription Drugs, OTC Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HPGC
- Simcere
- Hailisheng
- Sichuan Weiao
- Shanxi Kangxin
- Ipsen
- Evaluate
- Potion-Pharm
- Gamay
- HPGC
Highlights of The Diarrhea Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Drugs
- OTC Drugs
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diarrhea Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diarrhea drug is a medication that is used to treat diarrhea. It can be taken by mouth or by injection.
Some of the key players operating in the diarrhea drug market are HPGC, Simcere, Hailisheng, Sichuan Weiao, Shanxi Kangxin, Ipsen, Evaluate, Potion-Pharm, Gamay, HPGC.
The diarrhea drug market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diarrhea Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diarrhea Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diarrhea Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diarrhea Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diarrhea Drug Market Size & Forecast, 2020-2028
4.5.1 Diarrhea Drug Market Size and Y-o-Y Growth
4.5.2 Diarrhea Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Prescription Drugs
5.2.2 OTC Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diarrhea Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diarrhea Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Prescription Drugs
9.6.2 OTC Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Prescription Drugs
10.6.2 OTC Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Prescription Drugs
11.6.2 OTC Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Prescription Drugs
12.6.2 OTC Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Prescription Drugs
13.6.2 OTC Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diarrhea Drug Market: Competitive Dashboard
14.2 Global Diarrhea Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 HPGC
14.3.2 Simcere
14.3.3 Hailisheng
14.3.4 Sichuan Weiao
14.3.5 Shanxi Kangxin
14.3.6 Ipsen
14.3.7 Evaluate
14.3.8 Potion-Pharm
14.3.9 Gamay
14.3.10 HPGC
